With Jazz Pharmaceutical Plc in the acquisition of Gentium Spa

Gattai Minoli & Partners has assisted Jazz Pharmaceutical Plc, an Irish pharmaceutical company listed on Nasdaq, in the important acquisition of Italian company Gentium S.p.A., also listed on Nasdaq.

The circa USD 1 billion transaction foresees that, at the end of the offer period, Jazz Pharma will pay USD 57 per share of Gentium S.p.A., an Italian bio-pharmaceutical company incorporated back in 1993, which develops new drugs mainly for coagulation illnesses.

Gattai Minoli & Partners, with a team formed by Partners Bruno Gattai and Nicola Brunetti, as well as by Associate Michele Ventura, has assisted Jazz Pharmaceutical together with International Law Firms Weil, Gotschal & Manges LLP, Baker & McKenzie, Cooley LLP and Hogan Lovells.